<DOC>
	<DOCNO>NCT02597153</DOCNO>
	<brief_summary>To study efficacy safety Mitoxantrone HCL Liposome Injection patient relapse cutaneous T cell lymphomasell</brief_summary>
	<brief_title>Phase II Clinical Study PLM60 Treatment Cutaneous T Cell Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<criteria>The subject voluntary sign inform consent form ; ECOG score 0 2 ; The expect survival time ≥3 month ; Patients cutaneous Tcell lymphoma confirm histopathology , measurable lesion , without systemic lymph node involvement ; clinical stage IBIVA ; The patient previously receive least systemic therapy ( include systemic electron beam irradiation chemotherapy , stem cell transplantation ) achieve remission ( include remission period shorter 30 day treatment ; An interval least four week target tumor treat chemotherapy , radiotherapy , biological therapy , stem cell transplantation study drug ; Subjects childbearing age agree take effective contraceptive measure study ; blood pregnancy test result negative ( except infertility due menopause operation ) ; Laboratory test ( blood routine , liver kidney function ) meet following requirement : 1 . ANC≥ 1.5×109/L ; b ) PLT ≥ 75×109/L ; c ) Hb ≥ 9 g/dL ; ) Cr ) ≤ 1.5x ULN ; e ) TBIL ≤ 1.5x ULN ; f ) AST ALT ≤2.5 x ULN . Pregnant lactate woman ; An allergic history anthracyclines liposome drug ; Disease progression recurrence anthracycline treatment within six month enrollment ; '' Patients use mitoxantrone injection ; Patients use doxorubicin ( pirarubicin ) total cumulative dose &gt; 360mg/m2 , epirubicin total cumulative dose &gt; 600mg/m2 ; Left ventricular ejection fraction &lt; 50 % &lt; low limit normal ; clinically significant QT interval prolongation ( &gt; 450ms male , &gt; 470ms female ) ; past history cardiac disease cause anthracyclines ; history severe heart disease ; Concomitant treatment anticancer drug need ; With internal organ involvement ( include bone marrow , central nervous system ; Clinically active infection significantly affect clinical trial ; Within 6 week organ transplantation major organ surgery ; Those inappropriate enrol evaluated researcher .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>